The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model.

Masahiro KagabuNaoto YoshinoTatsunori SaitoYuki MiuraRyosuke TakeshitaKazuyuki MurakamiHideki KawamuraTsukasa BabaToru Sugiyama

Published in: International journal of clinical oncology (2020)

These results demonstrate that T-01 has cytotoxic efficacy and inhibited against HPV-related cervical cancer cells. These findings indicate that T-01 has therapeutic potential for HPV-related cervical cancer.

Keyphrases

high grade
sars cov